Gastric cancer (GC) is the fourth and fifth most common cancer in men and women, Respectively.
Chromosome instability, caused by ectopic centriolar amplification, is ubiquitous in human malignancies, and occurs approximately in 50% of GC. 3 SCL/TAL1 interrupting locus (STIL) is a critical regulator of mitotic centrosome to promote the centriolar replication and cell cycling. 4 During the process of cell cycling, STIL expression is induced in an immediate early fashion, reaches the peak levels in mitosis and is degraded after cell cycle exits from mitosis. 5 STIL through its coiled-coil and STAN domains can interact with Polo-like kinase 4, cyclin dependent kinase 1 (CDK1) and SAS-6 to promote centriole duplication and maintain chromosome stability. 6 It is notable that STIL expression is elevated in multiple types of cancers, such as lung cancer and pancreatic cancer and correlated with the expression of several checkpoint genes and mitotic indicators. 7, 8 Furthermore, STIL has been reported to be one of the up-regulated 17 genes in primary adenocarcinoma and their elevated expression is associated with metastasis. 9 Hence, STIL acts as an oncogenic factor to promote the progression of several types of cancers. However, the role of STIL in the development and progression of GC has yet been explored. We aimed to examine the expression of STIL in clinical specimens and human GC cells, investigate the impact of STIL silencing on the malignant behaviors of GC cells in vitro and in vivo, and explore the potential mechanisms underlying the action of STIL in gastric carcinogenesis and progression.
| MATERIAL S AND ME THODS

| Tissue microarray and immunohistochemistry
The Tissue microarray (TMA), including 100 GC and 80 para-tumor tissues, was purchased from Shanghai Outdo Biotech (Catalog no. were de-paraffinized and rehydrated, followed by antigen retrieval in citrate buffer in a pressure cooker. The TMA sections were treated with 3% hydrogen peroxide for 10 minutes to block the endogenous peroxidase activity and 3% bovine serum albumin. Subsequently, the sections were probed with polyclonal anti-STIL (Abcam, USA, 1:100) at 4°C overnight. The bound antibodies were detected with horseradish peroxidase (HRP)-conjugated second antibodies and visualized using the chromogen of diaminobenzidine, followed by counterstained with hematoxylin.
The intensity of anti-STIL staining was scored by two pathologists using the Image-Pro Plus 6.0 software in a blinded manner. The scores were determined based on the percentages of positive area (a) and staining density (b) and the values of staining index (a × b)
were calculated. The samples were stratified by the median value of staining index for high or low STIL expression.
| TCGA dataset analysis
gastric cancer mRNA data were downloaded from the TCGA database. A total of 402 files, containing 375 tumor and 32 non-tumor tissues, were available for analysis. We employed the R package of "Edger" to screen differentially expressed genes (DEGs) and analyzed the levels of STIL expression in GC and matched non-tumor tissues.
| Cell culture and lentivirus transfection
Human 
| Quantitative reverse PCR
Total RNA was extracted from individual cell lines using HP Total 
| Western blotting
The cells were harvested and lyzed in RIPA buffer, followed by cen- 
| Proliferation assay
| Colony formation assay
| Flow cytometry for cell cycle and apoptosis
After 
| Xenografted tumor model
The 
| Gene microarray and bioinformatics
SGC-7901/shCon and SGC-7901/shSTIL cells were harvested and their total RNA was extracted. After quantity and quality of RNA samples using NanoDrop 2000 in an Agilent Bioanalyzer 2100, the transcriptome profiles were assessed with the PrimeView Human Gene
Expression Array (Affymetrix, USA), according to the manufacturer's instructions. Briefly, the RNA samples were reversely transcribed into cDNA that were used as the templates, followed by biotin-labelling using the GeneChip 3'IVT Expression Kit (Affymetrix). The microarray hybridization, washing and staining were performed using GeneChip Hybridization Wash and Stain Kit (Affymetrix). The microarrays were scanned using the GeneChip Scanner 3000 7G to produce raw data.
The DEGs were determined with criteria of a P < 0.05 or absolute Fold
Change > 1. The potential functional pathways of DEGs were analyzed by Ingenuity Pathways Analysis software.
| Statistical analysis
Statistical analyses were performed using the SPSS 17.0 and R software. Continuous data are expressed as mean ± SD and analyzed by Student's t test for variables normally distributed or U test for nonparametric variables. Survival curves were plotted using the R software.
The difference was considered statistically significant when a P < 0.05.
| RE SULTS
| Up-regulated STIL expression is associated with the progression of GC
To determine the potential role of STIL in the development of GC, the expression levels of STIL in 100 GC and 80 non-tumor stomach tissues were determined by TMA-based immunohistochemistry. As shown in Figure 1A , the STIL expression was up-regulated in GC compared with that in adjacent non-tumor tissues. The positivity rate of anti-STIL staining in GC tissues (63%) was significantly higher than 43.8% in adjacent non-tumor tissues (P = 0.01). Moreover, TCGA data indicated that the relative levels of STIL mRNA transcripts in 375 GC tissues were significantly higher than that in 32 non-tumor tissues ( Figure 1B ).
In addition, varying levels of STIL mRNA transcripts were detected in the different human GC cell lines ( Figure S1 ). Stratification analysis indicated that the positivity rate of high STIL expression was only significantly associated with T stage of GC in this population (P = 0.006), but not with other clinical parameters ( Table 1 ). Further analysis revealed that high STIL expression was a risk factor of poor overall survival in GC patients in this population ( Figure 1C , Table 1 ). Hence, up-regulated STIL expression was associated with the progression of GC.
| STIL silencing suppresses the proliferation and clonogenicity of GC cells in vitro
Next, we employed lentivirus-mediated STIL-specific shRNA expres- Figure 2C ). Collectively, such data indicated that STIL silencing inhibited the proliferation and clonogenicity of GC cells in vitro.
| STIL silencing retards the tumor growth in vivo
To further understand the role of STIL in the progression of GC, BALB/c nude mice were implanted with BGC-823/shCon or BGC-823/shSTIL and the dynamic growth of implanted tumors was monitored up to 21 days post inoculation. The dissected tumors were photoimaged in Figure 3A and the dynamic growth of BGC-823/shSTIL tumors was significantly retarded, as compared with that in the BGC-823/shCon group (P < 0.05, Figure 3B ). Furthermore, the weights of BGC-823/ shSTIL tumors were significantly less than that of BGC-823/shCon tumors (P < 0.05, Figure 3C ). Thus, STIL silencing attenuated the growth of human GC tumors in mice.
| STIL silencing induces cell cycle arrest in G2/M phase and apoptosis of GC cells
To understand the mechanisms underlying the action of STIL silencing in inhibiting the proliferation of GC cells, the impact of STIL silencing on cell cycling and apoptosis of GC cells was determined by flow cytometry. As shown in Figure 4A 
| STIL silencing modulates the global gene expression profiling and signaling in GC cells
To gain new insights into the mechanisms by which STIL regu- 
| D ISCUSS I ON
SCL/TAL1 interrupting locus has been thought to be an oncogenic factor and its expression is up-regulated in many types of malignancies. However, there is no report on its role in the progression of GC. In this study, we found that up-regulated STIL expression was significantly associated with T stage and poor overall survival of GC patients. Knockdown of endogenous STIL inhibited the proliferation Previous studies have shown that STIL mutation causes the leftright asymmetry defects in mouse, 10, 11 disorganized mitotic spindles in zebrafish 12 and primary microcephaly in human. 13 However, pathway has been reported to be highly activated in the mesenchymal phenotype of GC characterized by a poor prognosis and resistance to chemotherapy compared with the epithelial phenotype. 19 Given that the IGF-1/PI3K/AKT pathway is crucial for GC carcinogenesis and progression, STIL-targeted strategy may be promising for treatment of GC. Nevertheless, the exact mechanisms by which STIL silencing greatly reduced IGF1R expression in GC cells remain elusive and they, together with therapeutic effect of SC79 on the growth of GC in vivo, deserve to be further investigated. Using bioinformatics analysis, we identified SP3 with a zinc finger domain as the transcription factor of IGF1R (Table S1 ). Based on the interactome landscape from BioGRID, 20 STIL may interact with ubiquitin-specific protease 7 (USP7), 21 which represses the auto-ubiquitination of checkpoint with forkhead and ring finger domains (CHFR)-E3 ubiquitin ligase. 22 Intriguingly, SP3 was predicted as a high-score substrate of CHFR by the UbiBrowser. 23 Taken together, STIL regulates oncogenic IGF-1/PI3K/AKT pathway in GC, which may attribute to its interaction with the USP7/CHFR/SP3 signaling axis. 
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